Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 840-844

Spandidos Publications

Access to resources Recommend Favorite

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-01 ,pp. : 2083-2087

Spandidos Publications

Access to resources Recommend Favorite

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

By Maas K.W.   van der Lee I.   Bolt K.   Zanen P.   Lammers J.W.J.   Schramel F.M.N.H.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

By Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite

Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 1017-1022

Spandidos Publications

Access to resources Recommend Favorite